Total raised
$4.4M
Last: Seed 2025-03
Stage
Seed
Founded
2016
Headcount
4
HQ
Jerusalem
Sector
Health Tech & Life Sciences
About
Gyntools provides GYNI- an AI-based accurate, rapid point-of-care diagnostic system for vaginitis, the most common gynecological problem that is misdiagnosed today in 50% of first clinic visits.
The company's product is AMAR & CE approved and we started commercialization in Israel and Europe, while preparing for US FDA submission under 510(k) & CLIA waiver. GYNI has granted patents.
Funding history · 3 rounds · $4.4M total
2025-03
Seed
$1.7M
2021-12
Seed
$350K
2018-12
Seed
$1.0M
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical Diagnostics
Technologies
Artificial IntelligenceDeep Learning
Target customers
Healthcare & Life SciencesHealthcareInsurance CompaniesProvidersConsumersDemographics & FamilyWomen
Business model
B2B
Highlights
1 PatentsVerified
Tags
femtechdeep-learningautomationmhealthmedical-technologieshospitalsclinicsartificial-intelligencehealthcare-providersdigital-healthcaredoctorsdiagnosticsgynecologydetectionwomen-healthinsurance-companies